Growth without growth hormone receptor:: Estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis

被引:56
|
作者
Venken, K
Schuit, F
Van Lommel, L
Tsukamoto, K
Kopchick, JJ
Coschigano, K
Ohlsson, C
Movérare, S
Boonen, S
Bouillon, R
Vanderschueren, D
机构
[1] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Div Biochem, Gene Express Unit, B-3000 Louvain, Belgium
[3] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA
[4] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA
[5] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Ctr Bone Res, Gothenburg, Sweden
[6] Katholieke Univ Leuven, Univ Louvain, Ctr Metab Bone Dis, Louvain, Belgium
[7] Katholieke Univ Leuven, Div Geriatr Med, Louvain, Belgium
关键词
growth hormone receptor knockout mouse; bone; estrogens; IGF-I; liver gene expression;
D O I
10.1359/JBMR.050811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of estrogens in the regulation of pubertal growth independently of GH and its receptor was studied in male mice with disrupted GHRKO. E-2 rescued skeletal growth rates in GHRKO associated with an increase in hepatic and serum IGF-I. These data show that E-2 rescues pubertal growth during GH resistance through a novel mechanism of GHR-independent stimulation of hepatic IGF-I production. Introduction: Growth hormone (GH) and estrogen play a pivotal role in pubertal growth and bone mineral acquisition. Estrogens can affect GH secretion and thereby provide a GH-dependent mechanism for their effects on skeletal growth. It is presently unclear if or to what extent estrogens are able to regulate pubertal growth and bone mineral accrual independently of GH and its receptor. Materials and Methods: Estradiol (E-2; 0.03 mu g/day by subcutaneous silastic implants) was administered to orchidectomized (ORX) male mice with disrupted GHR (GHRKO) and corresponding WTs during late puberty (6-10 weeks). Longitudinal and radial bone growth, IGF-I in serum and its expression in liver, muscle, and bone, and liver gene expression were studied by histomorphometry, RIA, RT-PCR, microarrays, and Western blotting, respectively. Results: E-2 stimulated not only longitudinal (femur length and growth plate thickness) and radial growth (cortical thickness and periosteal perimeter), but also rescued longitudinal and periosteal growth rates in ORX GHRKO, whereas no significant changes occurred in WT. E-2 thereby upregulated serum IGF-I and liver IGF-I synthesis (+21% and +52%, respectively) in ORX GHRKO, whereas IGF-I synthesis in femur or muscle was unaffected. Study of the underlying mechanism of the stimulation of hepatic IGF-I expression showed that E-2 restored downregulated receptor signaling systems, such as the estrogen receptor alpha and the prolactin receptor. E-2 thereby recovered the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway as evidenced by a significantly increased activation of the transcription factor STAT5 in ORX GHRKO. Conclusions: Our data show a stimulation of skeletal growth through upregulation of hepatic IGF-I by a hormone other than GH. E-2 rescues pubertal skeletal growth during GH resistance through a novel mechanism of GHR-independent stimulation of IGF-I synthesis in the liver.
引用
收藏
页码:2138 / 2149
页数:12
相关论文
共 50 条
  • [1] Growth without growth hormone receptor:: Estradiol is a major growth-hormone independent regulator of hepatic insulin-like growth factor-I synthesis
    Venken, K
    Boonen, S
    Kopchick, J
    Coschigano, K
    Movérare, S
    Bouillon, R
    Ohlsson, C
    Vanderschueren, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S43 - S43
  • [2] Growth Hormone/IGF-I Axis and Growth Hormone Receptor Mutations in Idiopathic Short Stature
    El Kholy, M.
    Mella, P.
    Rashad, M.
    Buzi, F.
    Meazza, C.
    Zahra, S.
    Elsedfy, H. H.
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 76 (05): : 300 - 306
  • [3] Growth hormone and IGF-I in diabetic children with and without microalbuminuria
    Verrotti, A
    Cieri, F
    Petitti, MT
    Morgese, G
    Chiarelli, F
    DIABETES NUTRITION & METABOLISM, 1999, 12 (04) : 271 - 276
  • [4] IGF-I treatment of growth hormone insensitivity
    Rosenfeld, RG
    MOLECULAR MECHANISMS TO REGULATE THE ACTIVITIES OF INSULIN-LIKE GROWTH FACTORS, 1998, 1151 : 359 - 364
  • [5] Fractionation of growth plate chondrocytes: Differential expression of IGF-I and growth hormone and IGF-I receptor mRNA in purified populations
    Oberbauer, AM
    Peng, R
    CONNECTIVE TISSUE RESEARCH, 1995, 31 (03) : 179 - 187
  • [6] Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism
    Wilson, ME
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11): : 4013 - 4021
  • [7] Analysis of the human growth hormone receptor and IGF-I coding sequences in children with growth disorders
    Obrepalska-Steplowska, A
    Kedzia, A
    Gozdzicka-Józefiak, A
    Jakubowicz, M
    Korman, E
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (06): : 819 - 825
  • [8] Hormone replacement therapy in children: The use of growth hormone and IGF-I
    Pfaeffle, Roland
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 29 (03) : 339 - 352
  • [9] IMPAIRED SECRETION OF GROWTH HORMONE-RELEASING HORMONE, GROWTH-HORMONE AND IGF-I IN ELDERLY MEN
    BANDO, H
    ZHANG, CY
    TAKADA, Y
    YAMASAKI, R
    SAITO, S
    ACTA ENDOCRINOLOGICA, 1991, 124 (01): : 31 - 36
  • [10] Growth hormone, IGF-I and diabetic angiopathy revisited
    Moller, N
    Orskov, H
    CLINICAL ENDOCRINOLOGY, 2000, 52 (01) : 11 - 12